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Abstract Co-expression in Escherichia coli of wild-type (wt)
hepatitis B virus core protein (HBc) and its naturally occurring
variants with deletions at amino acid positions 77^93 or 86^93
leads to formation of mosaic particles, which consist of three
dimer subunit compositions. These compositions are wt/variant
HBc heterodimers and two types of homodimers, formed by wt
HBc or the variant HBc themselves. Mosaic particles were
found also when both HBc deletion variants 77^93 and 86^93
were co-expressed in E. coli. These ¢ndings are discussed in
terms of their signi¢cance for hepatitis B virus pathogenesis
and prospective use of mosaic particles in vaccine development.
* 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Chronic infection with hepatitis B virus (HBV) may lead to
liver cirrhosis and hepatocellular carcinoma. HBV genomes
with internal in-frame C gene (HBV core protein (HBc)
gene) deletions have been found frequently in chronic HBV
carriers, including long-term immunosuppressed renal trans-
plant recipients with development of end-stage liver disease
[1,2]. Although their role in the pathogenesis of HBV infection
remains unclear, their replication and enrichment appears to
depend on the presence and amount of the wild-type (wt) HBc
protein ([3^5], Meisel et al., unpublished data).
HBV nucleocapsids, or HBc particles, are formed by 90 or
120 HBc protein dimers [6]. The HBc protein contains four
Cys residues at positions 48, 61, 107, and 183. Upon oxida-
tion, Cys61 in one monomer can easily form a disul¢de bridge
to Cys61 in the second subunit of the dimer, whereas Cys183^
Cys183 disul¢des occur between dimers [7]. The tips of the
spikes (in the vicinity of amino acids (aa) 74^83) carry the
major immunodominant region (MIR) of the HBc and are
frequently deleted in naturally occurring HBV variants from
immunosuppressed renal transplant recipients [2].
Escherichia coli expression of naturally occurring HBc dele-
tion variants in the presence of wt HBc as an ‘assembly’ help-
er resulted in the appearance of mosaic HBc particles consist-
ing of both wt and HBc variants [8]. Here, mosaic particles
formed by co-expression of wt HBc and natural HBc deletion
variants are analyzed for their dimer composition. We provide
evidence for existence of heterodimers, along with variant and
wt homodimers, within mosaic particles for both investigated
HBc deletion variants lacking aa 77^93 (#77/93) and 86^93
(#86/93).
2. Materials and methods
2.1. Expression vectors and puri¢cation of HBc particles
HBV genomes carrying internal C-gene deletions of 8 and 17 co-
dons (designated, according to the codons deleted, as #86/93 and
#77/93) were polymerase chain reaction (PCR)-ampli¢ed and cloned
from sera of immunosuppressed renal transplant recipients with liver
cirrhosis and end-stage liver disease [2]. Expression of wt HBc in a
C-terminally truncated (‘short’) form (aa 1^144) was performed either
in the vector pT31, a pBR322 derivative (ColE1 replicon) providing
an ampicillin resistance [9], or in the vector pREPpT, a pREP4 de-
rivative (p15A replicon) providing a kanamycin resistance [8]. For
expression of the #77/93 variant in the short form, the respective
pT31 and pREPpT derivatives p77/93pT and pREP77/93pT were
used [8].
For expression of the wt HBc gene in full-length (‘long’) form, a
site-directed PCR mutagenesis was performed within the plasmid
pHBc3, a pBR322 derivative [10], to replace the C-terminal Cys183
codon TGT by the Ser-encoding TCT codon. This resulted in the
generation of the HBc3* plasmid, where the asterisk denotes the Cy-
s183Ser exchange in the corresponding HBc preventing its dimer oli-
gomerization. To express the C wt-long* gene from a pREP4-derived
plasmid, a PvuII fragment from pHBc3* harboring the entire expres-
sion cassette was inserted into SalI-restricted and Klenow-treated
pREP4 vector (Qiagen), resulting in the pREPc3* plasmid. For ex-
pression of the variant #86/93-long, the BglII fragment from the
pHBc3* vector was substituted by the corresponding fragment of
the p86/93 plasmid, resulting in the p86/93* plasmid.
HBc derivatives were expressed in E. coli K12 strain K802. The cells
were grown overnight in M9 medium supplemented with Casamino
acids (Difco), and puri¢cation of HBc particles was performed as
previously described [11]. Electron microscopy of particles was per-
formed after negative staining with uranyl acetate or phosphotungstic
acid in Zeiss EM 10A or JEM 100C electron microscope, respectively.
2.2. Sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) and immunoblotting
Electrophoresis was performed in 15% polyacrylamide gel (PAAG).
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Variant and wt HBc proteins were detected by immunoblotting with
the monoclonal anti-HBc antibody 13C9 recognizing the aa residues
136^144 [12] and anti-mouse IgG peroxidase conjugate (Dako Diag-
nostika).
2.3. Analysis of HBc dimers
To ¢x the intermolecular disul¢de bridges between monomers with-
in the dimers, puri¢ed HBc particles were treated with 100 WM CuSO4
according to Nassal et al. [7]. Samples were boiled for 10 min. To
avoid overoxidation, the treated samples were immediately mixed with
the sample bu¡er and loaded onto the SDS^PAGE. Gels were stained
with Coomassie brilliant blue. Dimer bands were cut from PAAG and
eluted in SDS^PAGE bu¡er (25 mM Tris; pH 8.3; 190 mM glycine;
0.1% SDS) with a Model 422 Electro-Eluter device (Biorad). Eluted
dimers were dissolved in Laemmli bu¡er containing 5% L-mercapto-
ethanol (L-ME) and analyzed by immunoblotting.
3. Results and discussion
3.1. Strategy for the analysis of the dimer subunit composition
of mosaic HBc particles
Although HBc dimers are suggested according to the X-ray
map [6] to contain intermolecular disul¢de bridges connecting
Cys61 residues, these disul¢de bridges appear only during
puri¢cation and storage but not during formation of HBc
particles in E. coli. In order to ¢x the dimers of the mosaic
particles covalently, we induced oxidation at the Cys61 [7]. To
avoid polymerization of dimers by formation of intermolecu-
lar Cys183 disul¢de bridges, the Cys183 codon was mutated
to a Ser codon in long wt and variant #86/93 HBc.
We combined long and short forms of wt and variant HBc
(#86/93 or #77/93) proteins in co-expression experiments with
di¡erent expression vector combinations, and expression
products were characterized for their solubility and assembly
competence (Table 1). Combination of compatible pBR322-
derived (ColE1 replicon) and pREP4-derived (p15A replicon)
vectors allowed us to vary the relative amounts of wt and
variant HBc proteins, since pREP-driven expression levels
were always lower for both HBc variants as well as for the
wt HBc. Use of short and long HBc forms ensured also a
better separation of homo- and heterodimers in SDS^PAGE
(Figs. 1^3).
3.2. The HBc variants #77/93 and #86/93 di¡er in their
assembly competence when expressed alone
The variant #86/93-long showed a similar level of accumu-
lation and particle formation as the wt HBc. No particles were
found for the variant #77/93-long (Table 1) and it was hardly
detectable even by immunoblotting, independently of the vec-
tor (pBR- or pREP-derived) used (data not shown). However,
the variant #77/93-short was expressed very e⁄ciently.
Although it was mostly insoluble, some particles in the
E. coli lysate demonstrated its principal self-assembly compe-
tence (Table 1). Comparable expression levels of #86/93-long
and wt-long proteins suggest that the low expression level of
the #77/93-long variant is caused by rapid protein degrada-
tion rather than by low transcription and/or translation
level.
3.3. Co-expression with the wt HBc improves solubility of the
#77/93-short variant
Presence of wt-short helper in both vector combinations led
to markedly improved solubility of the #77/93 variant (Table
1, Nos. 1, 2). When the variant #77/93-short was expressed
from the medium-copy number plasmid pREP4, but the wt
HBc from the high-copy number plasmid pT31 (Table 1, No.
2), the variant #77/93 was more soluble and its content in
puri¢ed particles was higher. This combination was selected
for dimer analysis of mosaic particles formed by short forms
of variant #77/93 and wt protein (Fig. 1).
A strong helper e¡ect of wt HBc on the solubility of the
#77/93-short variant was also found in one of the combina-
tions, where full-length wt HBc was used. Thus, a su⁄cient
amount of particles from co-expression of #77/93-short+wt-
Table 1
Particle formation and dimer composition after co-expression of wt and variant HBc by di¡erent vector combinations
No. Co-expression:
gene combination
Vector Solubilitya Self-assemblyb Composition of HBc particles (%)
Variantc Homodimersd
(variant/wt)
Heterodimerse
#77/93-short p77/93pT; pREP77/93pT + + 100 ^ ^
1 #77/93-short+wt-short p77/93pT+pREPpT ++ +++ 5^15 ND ND
2 #77/93-short+wt-short pREP77/93pT+pT31 +++ +++ 15^25 5^15/65^75 15^25
3 #77/93-short+wt-long* p77/93pT+pREPc3* ^ ^ ND ND ND
4 #77/93-short+wt-long* pREP77/93pT+pHBc3* +++ +++ 45^55 30^40/30^40 30^40
#77/93-long p77/93; pREP77/93 ^ ^ ^ ^ ^
5 #77/93-long+wt-short pREP77/93+pT31 +++ +++ 5^15 ND ND
6 #77/93-long+wt-long pREP77/93+pHBc3 +++ ++ 10^20 ND ND
#86/93-long p86/93 +++ +++ 100 ^ ^
7 #86/93-long*+wt-short p86/93*+pREPpT +++ +++ 35^45 5^15/30^40 50^60
8 #86/93-long+wt-long p86/93+pREPc3 +++ +++ ND ND ND
9 #86/93-long*+#77/93-short p86/93*+pREP77/93pT ++/++ ++ 50^60/40^50 ND ND
Asterisk (*) indicates the aa exchange Cys183Ser in the appropriate HBc. ND, not determined.
aDetermined by immunoblotting as: +++, more than 50% of speci¢c protein in soluble form; ++, 25^50% of protein soluble; +, 10^25% of
protein soluble; ^, no protein detected in soluble E. coli fraction.
bDetermined by electron microscopy of soluble fraction as: +++, level similar to wt, useful for dimer analysis; ++, low amount, useful only
for analysis of monomer content; +, only few particles detected; ^, no particles detected.
cDetermined by immunoblotting as an approximate percentage of variant HBc protein in the particle preparation after disruption of particles
under reducing conditions.
dDetermined by immunoblotting as an approximate percentage of two homodimer forms after disruption of particles under non-reducing condi-
tions.
eDetermined by immunoblotting as an approximate percentage of heterodimers after disruption of particles under non-reducing conditions.
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long* was puri¢ed when wt HBc was expressed from the high-
copy number vector pHBc3* and the variant from the me-
dium-copy number vector pREP77/93pT (Table 1, No. 4).
The reverse combination led to insoluble proteins (Table 1,
No. 3).
3.4. The wt HBc helper in£uences behavior of the #77/93-long,
but not of the #86/93-long variant
Co-expression with both forms of wt HBc helper markedly
enhanced accumulation and solubility of the #77/93-long var-
iant (Table 1, Nos. 5, 6). Although the wt-short protein ap-
peared to be slightly more e⁄cient in its helper activity, the
amount of the #77/93-long variant was insu⁄cient for the
dimer analysis (Table 1, No 5).
In regard to expression level, solubility, and self-assembly,
the #86/93-long* variant, when expressed alone, was similar
to the wt HBc (Table 1). Co-expression with wt HBc proteins,
short or long, resulted in a synthesis of both proteins in com-
parable amounts, as well as self-assembly. For dimer analysis,
particles from co-expression with wt-short (Table 1, No 7)
were selected, since this combination enabled good separation
of both proteins in PAGE (Fig. 2).
3.5. The amount of the HBc variants within the mosaic
particles depends on amount and form of co-expressed wt
HBc protein
The amount of assembled #77/93-short protein increased,
when wt-short protein was expressed from high-copy number
plasmid pT31 (Table 1, Nos.1 and 2). High-level expression of
the wt helper was absolutely necessary to form mosaic par-
ticles, when the wt-long was used in co-expression with the
#77/93-short protein (Table 1, Nos. 3, 4); in this case up to
55% of the #77/93-short were incorporated into mosaic par-
ticles (Table 1, No. 4).
A slightly higher incorporation level was observed for the
#77/93-long variant, when the wt-long helper was used, in
spite of less particles found in soluble E. coli fraction com-
pared to co-expression with the wt HBc-short (Table 1, Nos.
5, 6). It appears therefore, that full-length wt-HBc is more
reactive in interactions with its ‘analogue’ of low assembly
competence.
Mosaic particles were easily formed in co-expression of the
wt and the assembly-competent #86/93 variant. The variant
#86/93-long* was found incorporated in capsids at a share of
35^45% even when wt protein was expressed in short form
Fig. 1. SDS^PAGE analysis of mosaic particles formed by co-expression of the #77/93-short variant with the wt HBc. Puri¢ed particles were
disrupted under reducing (‘+’) or non-reducing (‘3’) conditions after CuSO4 treatment (100WM) and analyzed in PAAG by (a) Coomassie blue
staining and (b) immunoblotting with 13C9 antibody. A, B, and C show putative dimer bands in co-expressed particles. The content of the
bands from gel (a), lane 4, and gel (b), lane 6, after elution, treatment with Laemmli bu¡er containing L-ME, and immunoblotting with 13C9
antibody is shown in (c) and (d), respectively. Degradation products of wt HBc proteins are marked with (‡). M, molecular mass marker.
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from the medium-copy number pREP plasmid (Table 1, No.
7).
3.6. Heterodimers along with homodimers are found within
mosaic particles for all co-expression combinations
Three combinations: #77/93-short+wt-short, #77/93-
short+wt-long*, and #86/93-long*+wt-short (Table 1, Nos.
2, 4, 7) were selected for further analysis of dimer composi-
tion. The latter two were chosen, since they enabled good
separation of both co-expressed proteins in SDS^PAGE (see
Fig. 1b and Fig. 2a, lanes 5).
As shown in Fig. 1a (lane 4), 1b (lane 6), and Fig. 2a (lane
6), dimers were represented by three distinct bands (marked as
A, B, and C) of di¡erent molecular mass for all three combi-
nations. Calculation of the molecular mass of the expected
HBc dimers suggested that the A and C bands represented
homodimers formed by the wt HBc or the particular deletion
variant, whereas the B band represented the wt/variant hetero-
dimers.
3.7. Content of heterodimers is not lower than that of variant
homodimers in mosaic particles
Although wt HBc homodimers strongly dominated in the
mosaic particles formed by the wt-short and #77/93-short
proteins (Fig. 1a, lane 4, band A), the heterodimer content
(15^25%) was found slightly higher than the variant homo-
dimer content (5^15%), suggesting that the variant monomers
prefer to interact with the wt partners (Table 1, No. 2).
The heterodimer content in mosaic particles containing the
#77/93-short was markedly increased (to 30^40%) when the
wt-short helper was exchanged by the wt-long one (Table 1,
No. 4). Notably, increased heterodimer formation in this case
correlated with higher incorporation of the variant homo-
dimers (30^40%, compared to 5^15% incorporated in the co-
Fig. 2. Immunoblotting with 13C9 antibody of mosaic particles formed by co-expression of the #86/93-long* variant with the wt-short HBc.
(a) Puri¢ed particles were disrupted under reducing (‘+’) or non-reducing (‘3’) conditions. A, B, and C in lane 6 represent bands of putative
dimers in co-expressed particles. The content of the bands after elution, treatment with Laemmli bu¡er containing L-ME, and immunoblotting
with 13C9 antibody is shown in (b). Degradation products of wt HBc are marked with (‡). M, molecular mass marker.
Fig. 3. Electron microscopy (a) and immunoblotting (b) of mosaic particles formed by co-expression of the #86/93-long* and #77/93-short var-
iants. Mosaic particles were bound on protein A-Sepharose CL-4B beads coupled with monoclonal anti-HBc antibody C1-5 recognizing the aa
residues 78^83 [12] as described previously [8]. a: Electron microscopy of soluble E. coli fraction. Bar, 50 nm. b: Immunoblotting with 13C9
antibody of C1-5 antibody-bound and unbound proteins: 1, monomer content of particles used for precipitation; 2, negative control: CL-4B
Sepharose-bound C1-5 antibodies without adding of particles; 3, monomer content of C1-5 antibody-bound particles; 4 and 5, ammonium sul-
fate concentrated Sepharose-unbound material. M, molecular mass marker.
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expression with the wt-short), suggesting that heterodimers
may act as mediators attracting the variant homodimers to
the particle assembly.
Strong heterodimer dominance over variant homodimers
was observed in the co-expression of the #86/93-long* and
wt-short proteins (Fig. 2a, lane 6). This ¢nding was quite
surprising, since the #86/93-long variant is assembly compe-
tent and we expected a high proportion of the variant homo-
dimers in mosaic particles. We speculate that the #86/93-long
plays a role of an assembly helper and initiates heterodimer
formation with the truncated wt-HBc.
Therefore, self-assembly competence and composition of
mosaic particles depend widely on the length and localization
of the deletion within the HBc protein.
3.8. Simultaneous expression of the #86/93-long* and
#77/93-short variants leads to formation of mosaic
particles
As the #77/93 and #86/93 variants have emerged in the
same renal transplant recipient [2], we were intrigued to in-
vestigate the possible interaction of both variants. The combi-
nation of #86/93-long*+#77/93-short was used for co-expres-
sion in E. coli (Table 1, No 9). Although only a minor part of
the expression products was found soluble, particle formation
was detected (Fig. 3a, Table 1). Since the amount of particles
was found insu⁄cient for dimer analysis, puri¢ed particles
were analyzed for their monomer composition. Immunopre-
cipitation of particles with the C1^5 antibody, which recog-
nizes the #86/93, but not the #77/93 variant, resulted in co-
precipitation of the #77/93-short variant. Approximately
equal amounts of both proteins were found in the precipitated
material, con¢rming the mosaic structure of the particles (Fig.
3b, lane 3). The mutant variants like #86/93 can interact
therefore with other, assembly non-competent HBc deletion
variants in the infected organism, stabilizing and thus rescuing
them from degradation.
3.9. Structural and functional signi¢cance of mosaic HBc
particles
In-frame C-gene deletions are found frequently within the
HBc MIR, suggesting an underlying B cell immune escape
mechanism for their occurrence [1,2]. Many HBc gene dele-
tions are too large to conceive formation of a functionally
active protein [3^5]. However, one can imagine that the
MIR-shortened HBc variants may be rescued by the wt
HBc and involved in viral and/or cellular processes in HBV-
infected hepatocytes. Structurally, the heterodimers should be
able to tolerate the shortage of the HBc spikes after rear-
rangement of their K-helices in the MIR-shortened HBc
monomers (Fig. 4).
Appearance of heterodimers in our co-expression experi-
ments seems to be in con£ict with the earlier ¢nding that
the HBc monomers di¡ering only by an epitope tag show a
strong preference for forming homodimers rather than hetero-
dimers in Xenopus oocytes [13]. It cannot be excluded that
di¡erences in the experimental systems and the local concen-
trations of the di¡erent monomers could have contributed to
these varying ¢ndings.
In hepatocytes, the HBc variants could be involved in the
replication of HBV genomes by in£uencing the pregenome
encapsidation. Further, the HBc variants may disturb the
transcription regulatory function of HBc, which was demon-
strated recently [14], with possible fatal consequences for cel-
lular processes.
3.10. Perspectives of mosaic HBc particles in protein
engineering and vaccine development
In E. coli, recombinant mosaic HBc particles were em-
ployed, when the wt HBc helper enabled incorporation of
assembly incompetent HBc derivatives carrying C-terminally
fused foreign sequences [15]. However, the most promising
site for foreign insertions is represented by the HBc MIR
(for review see [16]). Arti¢cial deletions within the MIR are
able to abrogate the intrinsic HBc antigenicity/immunogenic-
ity and to enhance immunogenicity of inserted foreign sequen-
ces. Therefore, naturally occurring HBc deletion variants
could be considered as candidates for insertion of epitopes
and construction of mosaic particles with desired properties.
Additional investigations are needed to prove if the presence
of the wt helper and formation of mosaic particles might over-
come problems of poor solubility, instability, and assembly
competence of the HBc fusion proteins.
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